Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026)
Nuvectis Pharma's (NVCT) quarterly Prepaid Assets came in at $268000.0 in Q1 2026, down 5.63% year-on-year from $284000.0 in Q1 2025, and up 257.33% quarter-over-quarter from $75000.0 in Q4 2025.
Nuvectis Pharma (NVCT) Prepaid Assets (2021 - 2026) Analysis & Trends
Nuvectis Pharma has disclosed Prepaid Assets across 6 years of filings, most recently posting $268000.0 for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $268000.0, down 5.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $268000.0 (down 5.63% YoY), and the FY2025 annual result was $75000.0, up 1.35% from the prior year.
- Prepaid Assets came in at $268000.0 for Q1 2026 at Nuvectis Pharma, up from $75000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.2 million in Q3 2022 to a low of $59000.0 in Q4 2023.
- The 5-year median for Prepaid Assets is $250000.0 (2024), against an average of $364823.5.
- Across the five-year window, Prepaid Assets surged 352.75% in 2022 and tumbled 85.68% in 2023, its largest moves.
- Nuvectis Pharma's Prepaid Assets stood at $412000.0 in 2022, then sank by 85.68% to $59000.0 in 2023, then increased by 25.42% to $74000.0 in 2024, then climbed by 1.35% to $75000.0 in 2025, then jumped by 257.33% to $268000.0 in 2026.
- The last three Prepaid Assets figures came in at $268000.0 (Q1 2026), $75000.0 (Q4 2025), and $145000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Nuvectis Pharma | 274.90 Mn | 274.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 268,000.00 |
| Dec 31, 2025 | 75,000.00 |
| Sep 30, 2025 | 145,000.00 |
| Jun 30, 2025 | 214,000.00 |
| Mar 31, 2025 | 284,000.00 |
| Dec 31, 2024 | 74,000.00 |
| Sep 30, 2024 | 138,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 250,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 203,000.00 |
| Jun 30, 2023 | 341,000.00 |
| Mar 31, 2023 | 740,000.00 |
| Dec 31, 2022 | 412,000.00 |
| Sep 30, 2022 | 1.23 Mn |
| Jun 30, 2022 | 666,000.00 |
| Mar 31, 2022 | 925,000.00 |
| Dec 31, 2021 | 91,000.00 |